| Literature DB >> 27583098 |
Gabriel Olabiyi Ogun1, Amos Olufemi Adeleye2, Taiwo Olabimpe Babatunde1, Olufunmilola Abimbola Ogun3, Ayodeji Salami1, Biobele Jotham Brown4, Effiong Akang1.
Abstract
INTRODUCTION: Contrary to some earlier teachings that central nervous system (CNS) tumours are uncommon in black children, these neoplasms are the fourth most common paediatric tumours in Ibadan. Our centre is the major referral centre for CNS tumours in Nigeria. The last major study of paediatric CNS neoplasms from Ibadan was in 1985. An update of the data on paediatric CNS neoplasms at our centre is presented.Entities:
Keywords: CNS neoplasms; Ibadan; Nigeria; children; paediatric
Mesh:
Year: 2016 PMID: 27583098 PMCID: PMC4992396 DOI: 10.11604/pamj.2016.24.34.9344
Source DB: PubMed Journal: Pan Afr Med J
Age group distribution and WHO grades of CNS neoplasms of children in Ibadan
| WHO GRADE | ||||
|---|---|---|---|---|
| Age group (yrs) | I | II | III | IV |
|
| 11 | 4 | 6 | 10 |
|
| 15 | 4 | 3 | 5 |
|
| 10 | 4 | 1 | 4 |
|
| 36 | 12 | 10 | 19 |
Paediatric CNS neoplasms in Ibadan, Nigeria: gender and age group distribution of all tumours in the series
| Morphological subtype | GENDER | AGE GROUPSl | ||||
|---|---|---|---|---|---|---|
| M | F | M:F | 0-4 | 5-9 | 10-14 | |
|
| ||||||
| Pilocytic astrocytoma | 11 | 5 | 2.2:1 | 5 | 9 | 2 |
| Fibrillary astrocytoma | 1 | - | - | 1 | - | |
| Subependymal giant cell astrocytoma | - | 1 | - | - | 1 | |
| Glioblastoma | 1 | 1 | 1:1 | 1 | 1 | - |
|
| ||||||
| Myxopapillary ependymoma | - | 1 | - | 1 | - | |
| Ependymoma | 7 | 3 | 2.3:1 | 3 | 3 | 4 |
| Anaplastic ependymoma | 3 | 1 | 3:1 | 2 | 2 | - |
|
| ||||||
| Medulloblastoma | 5 | 8 | 1:1.6 | 8 | 3 | 2 |
| Ganglioneuroblastoma | 1 | - | - | 1 | - | |
| Ependymoblastoma | 1 | - | 1 | - | - | |
|
| ||||||
| Ganglioglioma | - | 1 | - | 1 | - | |
| Dysembryoplastic neuroepithelial tumour | 1 | - | - | - | 1 | |
|
| ||||||
| Pinealoblastoma | 1 | - | - | - | 1 | |
|
| ||||||
| Neurofibroma | - | 1 | - | - | 1 | |
|
| ||||||
| Meningioma | 2 | 3 | 1:1.5 | 2 | 1 | 2 |
| Haemangiopericytoma | - | 1 | 1 | - | - | |
| Lipoblastoma | 1 | - | 1 | - | - | |
|
| ||||||
| Yolk sac tumour | 2 | 2 | 1:1 | 3 | - | 1 |
| Immature teratoma | - | 1 | 1 | - | - | |
| Mixed germ cell tumour | 1 | - | - | 1 | - | |
|
| ||||||
| Craniopharyngioma | 5 | 4 | 1.3:1 | 3 | 3 | 3 |
|
| ||||||
| Metastatic neuroblastoma | 1 | - | - | - | 1 | |
|
| 44 | 33 | 31 | 27 | 19 | |
One case each of these group of tumours occured in the spinal canal
Paediatric CNS neoplasms in Ibadan, Nigeria: morphologic sub-types in relation to anatomical locations
| Morphological sub-types | Infratentorial | Supratentorial |
|---|---|---|
| Astrocytic tumours | 16 | 4 |
| Ependymal tumours | 6 | 9 |
| Embryonal tumours | 14 | 1 |
| Neuronal and mixed-glial tumours | 1 | 1 |
| Pineal region tumours | 0 | 1 |
| Germ cell tumours | 1 | 5 |
| Sellar region tumours | 0 | 9 |
| Meningeal tumours* | 0 | 6 |
| Nerve sheath tumours* | 0 | 0 |
| Metastatic tumour | 0 | 1 |
|
|
|
|
+One case each in these groups of tumours occurs in the spinal canal. They both were not included in this table
Paediatric CNS neoplasms in Ibadan, Nigeria: comparison of the two previous studies from Ibadan with the current study
| Current Study 2001-2010 | |||
|---|---|---|---|
|
|
|
|
|
| Glioblastoma | - | 1(1.3%) | 2(2.6%) |
|
|
|
|
|
|
|
|
|
|
| Medulloblastoma | 12(13%) | 8(10.6%) | 13(16.8%) |
|
| - | - |
|
|
|
|
|
|
|
| - | - |
|
| Pinealoblastoma | - | ||
|
| - | - |
|
|
|
|
|
|
| Meningioma | 1 | - | 5 |
|
|
|
|
|
| Immature teratoma | 2 | 1 | 1(1.3%) |
|
|
|
|
|
| Craniopharyngioma | 8(9%) | 12(16%) | 9 |
| Pituitary adenoma | 1(1%) | 3 | - |
|
|
|
|
|
| Neuroblastoma | 11(12%) | NS | 1 |
| Burkitt's lymphoma | 9(10%) | 7(9.3%) | - |
| Myeloid leukaemia | 1(1%) | NS | - |
Vascular tumours as a tumour group were classified in these series. Three cases in each series was not included in the table NS- Not Stated
Paediatric CNS neoplasms in Ibadan, Nigeria: comparison of current study findings with some other series from different parts of the world
| Study | Country | Total Number of cases | Maximum Age (years) | Relative frequency of four commonest CNS tumours | M:F ratio for all tumours | Mean age (years) | Supra- tentorial (%) | Infra-tentorial (%) | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | ||||||||
| Peris-Bonet et al.13 | Europe | 19,531 | <15 | Astrocytic tumours (40%) | PNET (including medulloblastoma) | Ependymoma | NS | NS | NS | NS | NS |
| Kaatsch et al.14 | Germany | 3,268 | <15 | Astrocytic tumours (41.7%) | Medulloblastoma (18.1%) | Ependymoma (10%) | PNET (6.4%) | 1.2:1 | 10.7 | 46.2 | 48.3 |
| Zhou D et al.15 | China | 1,485 | <17 | Astrocytic tumours (30.5%) | Craniopharyngioma (18.5%) | Medulloblastoma (14.6%) | Germ cell tumours (7.8%) | 1.6:1 | NS | 61.9 | 38.1 |
| Asirvatham et al.16 | India | 1,043 | <18 | Astrocytic tumours (47.3%) | Medulloblastoma (11.4%) | Craniopharyngioma (9.7%) | Ependymoma (4.8%) | 1.7:1 | 10.9 | 53.3 | 40.6 |
| Mehrazin et al.17 | Iran | 619 | <15 | Astrocytic tumours (40.4%) | Medulloblastoma (18.4%) | Ependymoma (10.5%) | Craniopharyngioma (8.8%) | 1.4:1 | 8.8 | 51 | 49 |
| Japan | 210 | <15 | Astrocytic tumours (35.7%) | Germ cell tumours (14.3%) | Craniopharyngioma (10.5%) | Medulloblastoma (10.0%) | 1.3:1 | NS | NS | NS | |
| Ahmed et al.21 | Pakistan | 81 | <15 | PNET (49.4%)++ | Astrocytic tumours (34.6%) | Ependymoma (10%) | Mixed glioneuronal tumours (5%) | 2.5:1 | 8.8 | 33.3 | 66.7 |
| Current study | Nigeria | 77 | <15 | Astrocytic tumours (25.9%) | Ependymoma (19.4%) | Medulloblastoma (16.8%) | Craniopharyngioma (11.6%) | 1.3:1 | 7.2 | 49.4 | 50.6 |
Intracranial and intraspinal germ cell tumours were excluded
These were population based studies
** included Medulloblastoma which accounted for 45.6% of tumours in the series NS- Not stated
Spinal Cord and meningeal tumours not included